Wenyong Tong, Ph.D.
Affiliations: | 2012 | Department of Pharmacology & Therapeutics | McGill University, Montreal, QC, Canada |
Area:
PharmacologyGoogle:
"Wenyong Tong"Mean distance: 42746.4
Parents
Sign in to add mentor| H Uri Saragovi | grad student | 2012 | McGill | |
| (Chemistry and biology of tumor-associated ganglioside GD2.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Galan A, Papaluca A, Nejatie A, et al. (2023) GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer. Frontiers in Oncology. 13: 1134763 |
| Tong W, Maira M, Roychoudhury R, et al. (2019) Vaccination with Tumor-Ganglioside Glycomimetics Activates a Selective Immunity that Affords Cancer Therapy. Cell Chemical Biology |
| Tong W, Maira M, Gagnon M, et al. (2015) Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology. Plos One. 10: e0134255 |
| Tong W, Sprules T, Gehring K, et al. (2012) Rational design of peptide ligands against a glycolipid by NMR studies. Methods in Molecular Biology (Clifton, N.J.). 928: 39-52 |
| Tong W, Gagnon M, Sprules T, et al. (2010) Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivity. Chemistry & Biology. 17: 183-94 |